Brain Advance Access originally published online on July 7, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 126, No. 9, 2052-2064,
September 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg208
Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology
1 Department of Human Anatomy and Genetics and 2 MRC Functional Genetics Unit, Department of Human Anatomy and Genetics, University of Oxford, Oxford, UK
Correspondence to: Kay Davies, MRC Functional Genetics Unit, Department of Human Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK E-mail: kay.davies{at}anat.ox.ac.uk
Autosomal recessive proximal spinal muscular atrophy (SMA) is a severe neurodegenerative disease of childhood causing weakness and wasting secondary to motor neuron dysfunction. Over 97% of cases are caused by deletions or mutations within the survival motor neuron (SMN) gene. The SMN protein is highly expressed within brain, spinal cord and muscle, and is decreased in SMA patients. It has been shown to have an important role in RNA metabolism, but the reason for the specific motor neuron loss is still unclear. We have used a novel antibody array technology to look for differences in the expression patterns of primary muscle cultures from a type II SMA patient and a normal control. A relatively small number of differences were found within a group of proteins that function as both RNA binding proteins and transcription factors. Interactions between a number of these proteins are well established, and three of them bind in turn to p53 which interacts with SMN. A number of the changes were confirmed with western blot analysis both in the primary muscle cultures and in skeletal muscle samples from SMA patients and controls. Changes at the mRNA level were also confirmed with oligonucleotide arrays. These results suggest that a common transcription pathway may be altered in the disease state, and suggests that down-regulation of transcription factors contributes to SMA pathogenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. M. Murray, L. H. Comley, D. Thomson, N. Parkinson, K. Talbot, and T. H. Gillingwater Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy Hum. Mol. Genet., April 1, 2008; 17(7): 949 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Lanaspa, N. E. Almeida, A. Andres-Hernando, C. J. Rivard, J. M. Capasso, and T. Berl The tight junction protein, MUPP1, is up-regulated by hypertonicity and is important in the osmotic stress response in kidney cells PNAS, August 21, 2007; 104(34): 13672 - 13677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Slevin, A. B. Elasbali, M. Miguel Turu, J. Krupinski, L. Badimon, and J. Gaffney Identification of Differential Protein Expression Associated with Development of Unstable Human Carotid Plaques Am. J. Pathol., March 1, 2006; 168(3): 1004 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Eckel-Passow, A. Hoering, T. M. Therneau, and I. Ghobrial Experimental Design and Analysis of Antibody Microarrays: Applying Methods from cDNA Arrays Cancer Res., April 15, 2005; 65(8): 2985 - 2989. [Abstract] [Full Text] [PDF]
|
|